Viatris is set to report its fourth-quarter earnings soon, with analysts forecasting a slight decline in profits.
What a time it’s been for Viatris. In the past six months alone, the company’s stock price has increased by a massive 41.5%, ...
Vertex Pharmaceutical (VRTX) stock gains as RBC Capital Markets upgrades the company to Outperform, citing a durable cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback